RANDOMIZED PHASE II TRIAL ON PRIMARY CHEMOTHERAPY WITH HIGH-DOSE METHOTREXATE (HD-MTX) ALONE OR ASSOCIATED WITH HIGH-DOSE CYTARABINE (HD-ARAC) FOR PATIENTS WITH PRIMARY CNS LYMPHOMA (IELSG # 20 TRIAL): TOLERABILITY, ACTIVITY AND SURVIVAL ANALYSES

Ferreri AJM;Reni M;Foppoli M;Martelli M;Siakantaris M;Frezzato M;Cabras MG;Fabbri A;Corazzelli G;Ilariucci F;Rossi G;Soffietti R;Stelitano C;Vallisa D;Zaja F;Gelemur M;Aondio GM;Avvisati G;Balzarotti M;Brandes A;Costa MJ;Gomez H;Guarini A;Pinotti G;Rigacci L;Uhlmann C;Ponzoni M;Zucca E;Caligaris-Cappio F;Cavalli F

2009-01-01